The Biden-Harris Administration has proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and Medicaid, sending the shares of Wegovy maker Novo Nordisk (NVO) and Zepbound maker Eli Lilly (LLY) higher on Tuesday. Meanwhile, Amgen (AMGN)… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id4028946/-Weight-loss-drugmakers-in-spotlight-as-White-House-proposes-coverage)
previous post